Future-case control crossover analysis for adjusting bias in case crossover studies
BMJ · 2023
DOI: 10.1136/bmj.p2136 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMJ, 2023. Verfasst von Wei-Ching Huang und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, 701 Tainan, Taiw…. Hauptthemen laut MEDLINE: Models, Statistical. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
This article outlines the issues of exposure time trends in the case crossover design and the implementation of the case-case-time-control design, a control crossover analysis using “future cases” to adjust the exposure time trends. The future-case control crossover analysis minimises the influence of constant time confounders, as well as the protopathic bias arising from exposure time trends.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, 701 Tainan, Taiwan.
- School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, 701 Tainan, Taiwan edward_lai@mail.ncku.edu.tw.
ORCID-Profile: Edward Chia-Cheng Lai
Zitieren
APA
Huang, W. C., & Lai, E. C. (2023). Future-case control crossover analysis for adjusting bias in case crossover studies. BMJ. https://doi.org/10.1136/bmj.p2136
Vancouver
Huang WC, Lai EC. Future-case control crossover analysis for adjusting bias in case crossover studies. BMJ. 2023. doi:10.1136/bmj.p2136
BibTeX
@article{Huang2023,
author = {Huang, Wei-Ching and Lai, Edward Chia-Cheng},
title = {Future-case control crossover analysis for adjusting bias in case crossover studies},
journal = {BMJ},
year = {2023},
doi = {10.1136/bmj.p2136}
}
EUVIMED